Cited by 555Cancer survivorship and carePharmacovigilance and Adverse Drug ReactionsStatistical Methods in Clinical Trials

The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.

How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

Fromme, Erik K., Eilers, Kristine M., Mori, Motomi, Hsieh, Yi-Ching, Beer, Tomasz M.·2004·Journal of Clinical Oncology

DOI 10.1200/jco.2004.03.025

Open this paper in CoChat — free account

Abstract

Purpose: Adverse events in chemotherapy clinical trials are assessed and reported by clinicians, yet clinician accuracy in assessing symptoms has been questioned. We compared patient reporting of eight symptoms using a validated instrument, the European Organization for the Research and Treatment of Cancer Quality-of-Life Questionnaire C30 (QLQ-C30 or QLQ) with physicians' reporting of the same symptoms in the study's adverse events log. Patients and Methods: Thirty-seven men with metastatic, androgen-independent prostate cancer enrolled onto a phase II trial of weekly calcitriol and docetaxel completed the QLQ every 4 weeks for up to 28 weeks. A patient-reported symptom was defined as an increase in a QLQ symptom score by at least 10 points (0 to 100 scale), sustained for at least 4 weeks. A physician-reported symptom was considered present if it was ever documented in the adverse event log. Results: Forty-nine (new or worsened) symptoms were detected by both physician and QLQ, 48 symptoms were detected by the physician alone, and 55 symptoms were detected by the QLQ alone. They agreed on the absence of a symptom in 102 instances of 254 possible opportunities. Their uncorrected agreement was 59.4%, but Cohen's κ, a coefficient of agreement that corrects for chance, was 0.15, indicating only slight agreement. Using the QLQ as the standard, overall physician sensitivity and specificity was 47% and 68%, respectively, although it varied considerably among symptoms. Conclusion: Even in a tightly controlled clinical trial, physician reporting was neither sensitive nor specific in detecting common chemotherapy adverse effects. Tools for collecting patient-reported adverse event data in chemotherapy clinical trials should be developed.

Integrity signals

Registry

Crossref · 10.1200/jco.2004.03.025

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
A Coefficient of Agreement for Nominal Scales
Cohen, J. (1960) · Educational and Psychological Measurement · doi:10.1177/001316446002000104 · Cited by 42,398
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Analysis of serial measurements in medical research.
Matthews, J. N. S., Altman, D. G., Campbell, M. J., & Royston, P. J. (1990) · BMJ · doi:10.1136/bmj.300.6719.230 · Cited by 3,137
High agreement but low Kappa: I. the problems of two paradoxes
Feinstein, A. R., & Cicchetti, D. V. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90158-l · Cited by 3,034
Interpreting the significance of changes in health-related quality-of-life scores.
Osoba, D., Rodrigues, G., Myles, J., Zee, B. C.-Y., & Pater, J. L. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.139 · Cited by 3,016
The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review
Sprangers, M. A. G., & Aaronson, N. K. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90052-o · Cited by 1,076
Untitled work
(1997) · PubMed · Cited by 762
National Institutes of Health State of the Science Conference Statement
(2005) · Sleep · doi:10.1093/sleep/28.9.1049 · Cited by 745
Patient-re ported complications and follow-up treatment after radical prostatectomy
Fowler, F. J., Barry, M. J., Lu‐Yao, G. L., Roman, A., Wasson, J. H., & Wennberg, J. E. (1993) · Urology · doi:10.1016/0090-4295(93)90524-e · Cited by 627

Flagged first, then by citations

Show all 32 references

2 of the 32 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Ingham J, Portenoy RK: The measurement of pain and other symptoms, in Doyle D, Hanks G, MacDonald N (eds): Oxford Textbook of Palliative Medicine (ed 2) . Oxford, Oxford University Press, pp 203,2001-222
Bruera E: Research into symptoms other than pain, in Doyle D, Hanks GWC, MacDonald N (eds): Oxford Textbook of Palliative Medicine (ed 2) . Oxford, Oxford University Press, pp 180,1998
10.1023/A:1008886200225 · DOI

Sorted by citations

Items 301–400 of 551

Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice
Campbell, R., King, M. T., Stockler, M. R., Lee, Y. C., Roncolato, F. T., & Friedlander, M. L. (2023) · Patient Related Outcome Measures · doi:10.2147/prom.s297301 · Cited by 13
Incorporating patient-reported outcomes in dose-finding clinical trials with continuous patient enrollment
Andrillon, A., Biard, L., & Lee, S. M. (2023) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2023.2236216 · Cited by 13
Making the Grade: The Impact of Low-Grade Toxicities on Patient Preference for Treatment With Novel Agents
Castellanos, E. H., Chen, S., Drexler, H., & Horn, L. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0177 · Cited by 13
Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy
Rydén, A., Blackhall, F. H., Kim, H. R., Pillai, R. N., Braam, L., Martin, M. L., & Walding, A. (2017) · Patient · doi:10.1007/s40271-017-0229-9 · Cited by 13
Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure
Feldman, E., Pos, F. J., Smeenk, R. J., van der Poel, H. G., van Leeuwen, P., de Feijter, J. M., Hulshof, M. C. C. M., Budiharto, T., Hermens, R., de Ligt, K. M., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2022.100775 · Cited by 13
Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapy
Dickson, N. R., Beauchamp, K. D., Perry, T. S., Roush, A., Goldschmidt, D., Edwards, M. L., & Blakely, L. J. (2024) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-024-00700-4 · Cited by 14
Pilot Testing a Web-Based System for the Assessment and Management of Chemotherapy-Induced Peripheral Neuropathy
Knoerl, R., Dudley, W. N., Smith, G., Bridges, C. M., Kanzawa-Lee, G. A., & Smith, E. (2016) · CIN Computers Informatics Nursing · doi:10.1097/cin.0000000000000320 · Cited by 13
Patient-reported quality of life and symptom burden measures in human papillomavirus associated oropharyngeal cancer – A review of the literature and PRO methodology
McDowell, L. J., Gough, K., King, M. T., Corry, J. F., & Rischin, D. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105309 · Cited by 13
Measuring side effects after radiotherapy for pharynx cancer
Jensen, K. (2007) · Acta Oncologica · doi:10.1080/02841860701481547 · Cited by 13
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy
Taira, N., Kikawa, Y., Iwamoto, T., Miyoshi, Y., Hara, K., Yoshitomi, S., Hikino, H., Takahashi, H., Takabatake, D., Kubo, S., et al. (2024) · Breast Cancer · doi:10.1007/s12282-023-01537-3 · Cited by 12
Adverse event monitoring in oncology clinical trials
Russell, J. S., & Colevas, A. D. (2013) · Clinical Investigation · doi:10.4155/cli.13.111 · Cited by 12
Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
Dong, L., Han, Z., Feng, Z., & Jia, Z.-Y. (2014) · Journal of International Medical Research · doi:10.1177/0300060513505808 · Cited by 12
Patient reported outcomes in evaluation of chemotherapy toxicity in women with gynecologic malignancies: A pilot study
Webster, E., Burke, W. M., Ware, H. M., Jones, B. A., Vattakalam, R. M., Tergas, A. I., Wright, J. D., & Hou, J. Y. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.07.008 · Cited by 12
Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence
Neuner, J. M., Weil, E., Fergestrom, N. M., Stolley, M. R., Kamaraju, S., Oxencis, C. J., Winn, A. N., Laud, P. W., & Flynn, K. E. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.03.001 · Cited by 12
Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform
Efficace, F., Patriarca, A., Luppi, M., Potenza, L., Caocci, G., Tafuri, A., Fazio, F., Cartoni, C., Petrucci, M. T., Carmosino, I., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.826040 · Cited by 12
The Potential Role of Symptom Questionnaires in Palliative and Supportive Cancer Care Delivery
Stover, A. M., & Basch, E. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0571-z · Cited by 12
Implementation and first results of a tablet-based assessment referring to patient-reported outcomes in an inpatient cancer care unit
Schuler, M. K., Trautmann, F., Radloff, M., Hentschel, L., Petzold, T., Eberlein-Gonska, M., Ehninger, G., & Schmitt, J. M. (2017) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2017.03.007 · Cited by 12
Web-based Health Survey Systems in Outcome Assessment and Management of Pain
Podichetty, V. K., Weiss, L. T., Fanciullo, G. J., & Baird, J. C. (2007) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00382.x · Cited by 12
Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial
Wintner, L. M., Sztankay, M. J., Abdel‐Razeq, H., Hamdan-Mansour, R. A., Caocci, G., Mouillet, G., Kikawa, Y., Shibata, N., Krishnamurthy, M. N., Joshi, A., et al. (2026) · The Lancet Oncology · doi:10.1016/s1470-2045(25)00679-5 · Cited by 11
Patient Reported Outcome Measurement (PROM) under real-life conditions of non-curable cancer outpatients with the Integrated Palliative Outcome Scale (IPOS) and NCCN-Distress Thermometer – A mixed methods study
Ratzel, E., Pretzell, I., Kindler, T., Weber, M., & Gerlach, C. (2024) · PEC Innovation · doi:10.1016/j.pecinn.2024.100264 · Cited by 11
Patients’ Communication Preferences Around Cancer Symptom Reporting During Cancer Treatment: A Phenomenological Study
Carrasco, S. (2021) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2021.12.4.2 · Cited by 11
Patient-centered dosing: oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC)
Loeser, A. L., Gao, L., Bardia, A., Burkard, M. E., Kalinsky, K. M., Peppercorn, J. M., Rugo, H. S., Carlson, M., Cowden, J., Glenn, L. K., et al. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06755-5 · Cited by 11
Measuring chronic myeloid leukaemia TKI-related toxic effects in the real world: a systematic review and critical assessment of content validity of patient-reported outcome measures
Smit, Y., Metsemakers, S. J. J. P. M., Janssen, J. J. W. M., Posthuma, E. F. M., Walraven, I., Hermens, R., & Blijlevens, N. M. A. (2023) · The Lancet Haematology · doi:10.1016/s2352-3026(23)00173-4 · Cited by 11
Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial
Budrukkar, A. N., Murthy, V., Kashid, S., Swain, M., Rangarajan, V., Laskar, S. G., Kannan, S., Kale, S. N., Upreti, R. R., Pai, P., et al. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.08.056 · Cited by 11
Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
Ooki, A., Morita, S., Tsuji, A., Iwamoto, S., Hara, H., Tanioka, H., Satake, H., Kataoka, M., Kotaka, M., Kagawa, Y., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3564 · Cited by 13
Development and preliminary testing of a brief clinical tool to enable daily monitoring of chemotherapy toxicity: The Daily Chemotherapy Toxicity self-Assessment Questionnaire
Maguire, R., Kotronoulas, G., Donnan, P. T., Paterson, C. C., McCann, L., Connaghan, J., Domenico, D. D., & Kearney, N. (2018) · European Journal of Cancer Care · doi:10.1111/ecc.12890 · Cited by 11
Physician vs Patient Assessment of Dyspnea During Acute Decompensated Heart Failure
Smithline, H. A., Caglar, S., & Blank, F. S. J. (2009) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2009.00127.x · Cited by 11
Editorial: The Patient Knows Best: Incorporating Patient-Reported Outcomes Into Routine Clinical Care
Nipp, R. D., & Temel, J. S. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx044 · Cited by 11
Implementation of a mobile inpatient quality of life (QoL) assessment for oncology nursing
Schuler, M. K., Trautmann, F., Radloff, M., Schmädig, R., Hentschel, L., Eberlein-Gonska, M., Petzold, T., Vetter, H., Oberlack, S., Ehninger, G., et al. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3163-9 · Cited by 10
Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
Veldhuijzen, E., Walraven, I., Mitchell, S. A., Moore, E. Y., McKown, S., Lauritzen, M., Kim, K. J., Belderbos, J. S. A., & Aaronson, N. K. (2020) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-020-00249-y · Cited by 10
Active surveillance of chemotherapy-related symptom burden in ambulatory cancer patients via the implementation of electronic patient-reported outcomes and sensor-enabled vital signs capture: protocol for a decentralised feasibility pilot study
Offodile, A. C., DiBrito, S. R., Finder, J. P., Shete, S. S., Jain, S., Delgado, D. A., Miller, C. J., Davidson, E., Overman, M. J., & Peterson, S. K. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057693 · Cited by 10
Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluation
Weitzman, E. R., Gaultney, A., von Scheven, E., Ringold, S., Mann, C. M., Magane, K. M., Lin, L., Leverty, R., Dennos, A. C., Hernandez, A., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-063675 · Cited by 12
A patient’s perspective on the side effects of tyrosine kinase inhibitors in the treatment of advanced and metastatic gastrointestinal stromal tumors
van de Wal, D., Venkatesan, S., Benson, C., van der Graaf, W. T. A., Johnson, C., Husson, O., & Sodergren, S. C. (2023) · Future Oncology · doi:10.2217/fon-2022-0730 · Cited by 10
Cardio-oncology and Cancer Rehabilitation: Is an Integrated Approach Possible?
Pituskin, E., Foulkes, S., Cox-Kennett, N., Driga, A., Dimitry, R., Thompson, R. B., Kirkham, A. A., Prado, C. M. M., Gyenes, G. T., & Haykowsky, M. J. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.09.024 · Cited by 10
Isotonic Phase I Cancer Clinical Trial Design Utilizing Patient-Reported Outcomes
Wages, N. A., & Lin, R. (2023) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2023.2288013 · Cited by 10
Current status and future perspectives of patient-reported outcome research in clinical trials for patients with breast cancer in Japan
Ohsumi, S., & Shimozuma, K. (2012) · Breast Cancer · doi:10.1007/s12282-012-0368-8 · Cited by 10
Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials
Basch, E., Thanarajasingam, G., & Dueck, A. C. (2022) · Clinical Trials · doi:10.1177/17407745221093922 · Cited by 10
Assessment of breast cancer disability: agreement between expert assessment and patient reports
Letellier, M.-È., & Mayo, N. E. (2016) · Disability and Rehabilitation · doi:10.3109/09638288.2016.1161846 · Cited by 10
Actual duration of patient-reported mucositis: Far longer than 2 to 4 weeks and may be avoidable altogether
McCullough, R. W. (2016) · Korean Journal of Clinical Oncology · doi:10.14216/kjco.16001 · Cited by 10
Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?
Sparano, F., Aaronson, N. K., Cottone, F., Piciocchi, A., Sala, E. L., Anota, A., Deliu, N., Kieffer, J. M., & Efficace, F. (2019) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0092 · Cited by 10
Clinician Report of Oral Oncolytic Symptoms and Adherence Obtained via a Patient-Reported Outcome Measure (PROM)
Nachar, V. R., Farris, K. B., Beekman, K., Griggs, J. J., Hough, S. M., & Mackler, E. R. (2019) · JCO Clinical Cancer Informatics · doi:10.1200/cci.18.00128 · Cited by 11
Initiatives for education, training, and dissemination of morbidity assessment and reporting in a multiinstitutional international context: Insights from the EMBRACE studies on cervical cancer
Kirchheiner, K., Smet, S., Spampinato, S., Jensen, N. B. K., Vittrup, A. S., Fokdal, L. U., Najjari-Jamal, D., Westerveld, H. G., Lindegaard, J. C., Kirisits, C., et al. (2020) · Brachytherapy · doi:10.1016/j.brachy.2020.08.011 · Cited by 10
Analysis of Patient-Reported Outcome Utilization Within National Clinical Trials Network Cooperative Group Radiation Oncology Trials Over the Past 2 Decades
Howell, J. N., Anker, C. J., Walker, A. J., Dorth, J. A., & Kharofa, J. R. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.12.007 · Cited by 10
Clinical and electromyography characteristics of chemotherapy-induced polyneuropathy
Kholodova, N. B., Ponkratova, Y. A., & Sinkin, M. V. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20171179159-66 · Cited by 9
The Role of Palliative Care in the Management of Patients with Lung Cancer
Tan, I. T., & Ramchandran, K. J. (2020) · Lung Cancer Management · doi:10.2217/lmt-2020-0016 · Cited by 9
Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials
TOMBAL, B. F., Freedland, S. J., Armstrong, A. J., Beer, T. M., Stenzl, A., Sternberg, C. N., Hussain, M., Ganguli, A. X., Ramaswamy, K., Bhadauria, H. S., et al. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00447-9 · Cited by 10
Self-citation
Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with Atezolizumab
Tan, J. Q. E., Abuhelwa, A. Y., Badaoui, S., Modi, N. D., Wiese, M. D., McKinnon, R. A., Sorich, M. J., & Hopkins, A. M. (2021) · Bladder Cancer · doi:10.3233/blc-211613 · Cited by 9
Exploring differences in symptomatic adverse events assessment between nurses and physicians in the clinical trial setting
Liu, L., Liu, Z., Ma, C., Cheng, M., Xie, Y., Zhang, L., & Wang, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-32123-4 · Cited by 9
Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer
Dohopolski, M. J., Diao, K., Hutcheson, K. A., Akhave, N. S., Goepfert, R. P., He, W., Lei, X. J., Peterson, S. K., Shen, Y., Sumer, B. D., et al. (2023) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2023.1323 · Cited by 9
A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer
Jordan, T., Nuamek, T., Fornacon-Wood, I., Califano, R., Coote, J. H., Harris, M., Mistry, H. B., Taylor, P., Woolf, D., & Finn, C. F. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1328871 · Cited by 9
Adverse Event Signal Detection Using Patients’ Concerns in Pharmaceutical Care Records: Evaluation of Deep Learning Models
Nishioka, S., Watabe, S., Yanagisawa, Y., Sayama, K., Kizaki, H., Imai, S., Someya, M., Taniguchi, R., Yada, S., Aramaki, E., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/55794 · Cited by 9
Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: a pooled analysis of two randomized trials
Kristensen, A. K., Solheim, T. S., Fløtten, Ø., & Grønberg, B. H. (2018) · Acta Oncologica · doi:10.1080/0284186x.2018.1492151 · Cited by 9
Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice
Pavlović, M., Šeparović, R., Vuger, A. T., & Vazdar, L. (2021) · Cancers · doi:10.3390/cancers13235922 · Cited by 9
Using ePROMs for follow-up after palliative radiotherapy: An exploratory study with patients and health care providers
Oldenburger, E., Neyens, I., Coolbrandt, A., Isebaert, S. F., Sevenants, A., Audenhove, C. V., & Haustermans, K. M. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2021.11.022 · Cited by 11
Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
Collomb, B., Dubromel, A., Caffin, A. G., Herledan, C., Larbre, V., Baudouin, A., Cerutti, A., Couturier, L., Maire, M., Karlin, L., et al. (2022) · Cancers · doi:10.3390/cancers14030660 · Cited by 9
Health-related quality of life before and during the COVID-19 pandemic in Switzerland: a cross-sectional study
Roser, K., Baenziger, J., Ilić, A., Mitter, V., Mader, L., Dyntar, D., Michel, G., & Sommer, G. (2023) · Quality of Life Research · doi:10.1007/s11136-023-03414-0 · Cited by 8
Capturing Acute Toxicity Data During Lung Radiotherapy by Using a Patient-Reported Assessment Tool
Tang, B., Giuliani, M., Le, L. W., Higgins, J., Bezjak, A., Brade, A. M., Cho, J., Sun, A. Y., & Hope, A. J. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.06.003 · Cited by 9
Changes in satisfaction in patients with gynaecological and breast malignancies: an analysis with the Socio-Economic Satisfaction and Quality of Life questionnaire
Fasching, P. A., Nicolaisen-Murmann, K., Lux, M. P., Bender, H., Ackermann, S., Beckmann, M. W., & Bani, M. R. (2007) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2007.00784.x · Cited by 9
Single Nucleotide Polymorphism TGFβ1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients
Smith, J. J., Wasserman, I., Milgrom, S. A., Chow, O. S., Chen, C., Patil, S. N., Goodman, K. A., & García‐Aguilar, J. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.12.015 · Cited by 9
Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer
Chung, Y., & Pui, N. N. M. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3684-x · Cited by 9
Child and parent preferences for graphical display of patient‐reported outcome data
Dobrozsi, S. K., & Panepinto, J. A. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26499 · Cited by 9
Symptomatic adverse events of chemotherapy in breast cancer patients:Using CTCAE, PRO-CTCAE, and EORTC QLQ-C30
Arahori, H., Kondo, K., Imai, Y., Bando, T., Inoue, H., Sasa, S., & Takizawa, H. (2024) · The Journal of Medical Investigation · doi:10.2152/jmi.71.82 · Cited by 8
Patient-Reported Outcomes Following Magnetic Resonance-Guided Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis
Westerhoff, J. M., Lalmahomed, T. A., Meijers, L. T. C., Henke, L. E., Teunissen, F. R., Bruynzeel, A. M. E., Alongi, F., Hall, W. A., Kishan, A. U., Intven, M., et al. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.05.028 · Cited by 8
Symptoms Relevant to Surveillance for Ovarian Cancer
Ore, R. M., Baldwin, L. A., Woolum, D., Elliott, E., Wijers, C. D. M., Chen, C., Miller, R. W., DeSimone, C. P., Ueland, F. R., Kryscio, R. J., et al. (2017) · Diagnostics · doi:10.3390/diagnostics7010018 · Cited by 8
Evaluation of skin reactions during proton beam radiotherapy – Patient-reported versus clinician-reported
Möllerberg, M., Langegård, U., Johansson, B., Ohlsson‐Nevo, E., Fransson, P., Ahlberg, K., Nyström, P. W., & Sjövall, K. (2021) · Technical Innovations & Patient Support in Radiation Oncology · doi:10.1016/j.tipsro.2021.05.001 · Cited by 8
Self-reported symptom study of COVID-19 chemosensory dysfunction in Malaysia
Lee, S., Yeoh, Z. X., Sachlin, I. S., Gazali, N., Soelar, S. A., Foo, C. Y., Low, L. L., Alwi, S. B. S., Kamalden, T. M. I. T., Shanmuganathan, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06029-6 · Cited by 8
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma
Unger, J. M., Darke, A. K., Othus, M. K. D., Truong, T., Khushalani, N. I., Kendra, K. L., Lewis, K. D., Faller, B. A., Funchain, P., Buchbinder, E. I., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.5486 · Cited by 8
Long Term Patient Reported Urinary Function Following External Beam Radiotherapy for Prostate Cancer
Chin, S., Hayden, A. J., Gebski, V., Cross, S., & Turner, S. (2017) · Clinical Oncology · doi:10.1016/j.clon.2017.01.043 · Cited by 8
Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers
Wong, R. L., & Morgans, A. K. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-0890-3 · Cited by 8
Patient-Reported Outcomes Bridge an Important Gap in Identifying Risk for Early Endocrine Therapy Discontinuation
Wagner, L. I. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab024 · Cited by 8
Development and validation of a coding framework to identify severe acute toxicity from systemic anti-cancer therapy using hospital administrative data
Boyle, J. M., Cowling, T. E., Kuryba, A., Fearnhead, N. S., van der Meulen, J., Braun, M. S., Walker, K., & Aggarwal, A. K. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102096 · Cited by 9
Experiences of Inpatient Bone Marrow Transplantation Nurses and Providers Using Electronic Symptom Reporting
Bryant, A. L., Coffman, E. M., Bullard, E., Hirschey, R., Bradley, J., Stover, A. M., Wood, W. A., & Bennett, A. V. (2018) · Journal of Oncology Practice · doi:10.1200/jop.18.00074 · Cited by 8
Osteoarthritis of the knee in primary care
Dieppe, P. A. (2007) · BMJ · doi:10.1136/bmj.39412.592477.80 · Cited by 8
Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience
Laughlin, B., Bhangoo, R. S., Thorpe, C. S., Golafshar, M. A., DeWees, T. A., Anderson, J. D., Vern-Gross, T. Z., McGee, L. A., Wong, W. W., Halyard, M. Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.920739 · Cited by 7
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
Heumann, P., Aguado-Barrera, M. E., Avuzzi, B., Azria, D., Briers, E., Bultijnck, R., Choudhury, A., Ruysscher, D. D., Farcy‐Jacquet, M., Fonteyne, V., et al. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.11.015 · Cited by 9
SOHO State of the Art Updates and Next Questions | Measuring Patient-Reported Outcomes (PROs) and Treatment Tolerability in Patients With Hematologic Malignancies
Major, A., Dueck, A. C., & Thanarajasingam, G. (2024) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2024.07.018 · Cited by 7
Italian version of the M.D. Anderson Symptom Inventory—Head and Neck Module: linguistic validation
Greco, A., Orlandi, E. M., Mirabile, A., Takanen, S., Fallai, C., Iacovelli, N. A., Rimedio, A., Russi, E. G., Sala, M., Monzani, D., et al. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2701-1 · Cited by 7
Piloting a Survivorship Screening Tool in a Specialty Clinic for Survivors of Childhood Cancers
Fisher, A. P., Wortman, K., Kinahan, K. E., Kircher, S. M., Penedo, F. J., Weldon, C. B., Didwania, A. D., & Garcia, S. F. (2019) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2019.0079 · Cited by 7
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)
Caminiti, C., Bryce, J., Riva, S., Ng, D., Diodati, F., Iezzi, E., Sparavigna, L., Novello, S., Porta, C., Mastro, L. D., et al. (2022) · Tumori Journal · doi:10.1177/03008916221099558 · Cited by 7
Patient and Provider Perspectives on Symptom Monitoring During Outpatient Chemotherapy: Interview Study
Chen, L., Bartel, C., Cai, X., Cheng, Y., Perer, A., McClaine, S., Kairis, E., Durica, K. C., Huang, W., & Low, C. A. (2023) · JMIR Formative Research · doi:10.2196/46001 · Cited by 9
Chemotherapy-related cardiotoxicity
Aggarwal, S., Kamboj, J., & Arora, R. R. (2013) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944712474332 · Cited by 7
Agreement between patients and general practitioners on quality deviations during the cancer diagnostic pathway and associations with time to diagnosis
Jensen, H., Sperling, C. D., Sandager, M., & Vedsted, P. (2015) · Family Practice · doi:10.1093/fampra/cmv021 · Cited by 7
Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic Disparities
Lim, S. H.-S., Ip, E., Ng, W. L., Chua, W. M., Asghari, R., Roohullah, A., Descallar, J., Henderson, C., Spring, K. J., SOUZA, P. D., et al. (2019) · Cancers · doi:10.3390/cancers11091263 · Cited by 7
Adverse events of targeted therapies reported by patients with cancer treated in primary care
Roger, S., Edeline, J., Campillo‐Gimenez, B., Ventroux, E., Bugat, M.-È. R., & Chapron, A. (2020) · European Journal of General Practice · doi:10.1080/13814788.2020.1846713 · Cited by 7
Relationship between quality of life indicators and cardiac status indicators in chemotherapy patients
Geršak, B. M., Kukec, A., Steen, H., Montenbruck, M., Šoštarič, M., Schwarz, A. K., Esch, S., Kelle, S., Giuşcă, S., Korosoglou, G., et al. (2021) · Slovenian Journal of Public Health · doi:10.2478/sjph-2021-0028 · Cited by 7
Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry
Thorpe, C. S., DeWees, T. A., Golafshar, M. A., Bhangoo, R. S., Vern-Gross, T. Z., McGee, L. A., Wong, W. W., Halyard, M. Y., Keole, S. R., & Vargas, C. (2022) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00408-9 · Cited by 7
Electronic Monitoring of Patient-Reported Outcomes—Ready for Prime Time?
Velázquez, A. I., & Florez, N. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.2927 · Cited by 7
Comparing physicians’ and patients’ reporting on adverse reactions in randomized trials on acupuncture—a secondary data analysis
Schwaneberg, T., Witt, C. M., Roll, S., & Pach, D. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2638-x · Cited by 7
Future Trends in Patient-Reported Outcomes Assessment for Patients with Advanced-Stage Lung Cancer Receiving Targeted Therapy
Eton, D. T., Yost, K. J., & Cella, D. F. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.037 · Cited by 7
A model for assessment and referral of clients with bowel symptoms in community pharmacies
Sriram, D., McManus, A., Emmerton, L., Parsons, R. W., & Jiwa, M. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1135113 · Cited by 6
Impact of patient nationality on the severity of early side effects after radiotherapy
Köksal, M. A., Streppel, R., Hauser, S., Abramian, A., Kaiser, C., Gonzalez-Carmona, M. A., Feldmann, G., Schäfer, N., Koob, S., Banat, M., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04505-0 · Cited by 6
Experience of patients considering or using checkpoint inhibitors in cancer treatment: a systematic review of qualitative research
Yip, R., Arnolda, G., Lamprell, K., Easpaig, B. N. G., Chittajallu, R., Delaney, G. P., Olver, I., Liauw, W., & Braithwaite, J. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007555 · Cited by 8
Long-Term Patient-Reported Outcomes of Stereotactic Radiosurgery for Trigeminal Neuralgia
Yomo, S., Oda, K., & Oguchi, K. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.02.011 · Cited by 6
Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study
Roberts, N. A., Pelecanos, A. M., Alexander, K. E., Wyld, D., & Janda, M. (2024) · Journal of Medical Internet Research · doi:10.2196/55841 · Cited by 6
How patients being treated for non-small cell lung cancer value treatment benefit despite side effects
Martin, M. L., Correll, J. R., Walding, A., & Rydén, A. (2021) · Quality of Life Research · doi:10.1007/s11136-021-02882-6 · Cited by 6
Initial findings from a prospective, large scale patient reported outcomes program in patients with gynecologic malignancy
Sisodia, R. C., Alimena, S., Ferris, W., Saini, A., Philp, L., Sullivan, M. W., Dorney, K. M., Bregar, A. J., Eisenhauer, E. L., Goodman, A., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.10.084 · Cited by 6
Using a Weekly Patient-Reported Outcome Questionnaire to Track Acute Toxicity in Patients Undergoing Pelvic Radiotherapy for Gynecologic Cancers
Chan, M. M. K., Olson, R. A., Lapointe, V., Hamm, J., Bachand, F., Holloway, C. L., Parsons, C. A., & Lim, P. (2022) · Current Oncology · doi:10.3390/curroncol29050270 · Cited by 6
Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer
Zschaeck, S., Zöphel, K., Seidlitz, A., Zips, D., Kotzerke, J., Baumann, M. A., Troost, E. G. C., Löck, S., & Krause, M. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.10.030 · Cited by 6
The use of electronic Patient Reported Outcomes in follow-up after palliative radiotherapy: A survey study in Belgium
Oldenburger, E., Isebaert, S. F., Coolbrandt, A., Audenhove, C. V., & Haustermans, K. M. (2023) · PEC Innovation · doi:10.1016/j.pecinn.2023.100243 · Cited by 6
Assessing Treatment-Related Toxicity Using Administrative Data, Patient-Reported Outcomes, or Physician-Graded Toxicity: Where Is the Truth?
Groß, M., Awamlh, B. A. H. A., & Hu, J. C. (2019) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2019.05.007 · Cited by 6

Authors: Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y.-C., & Beer, T. M.
Affiliations: Oregon Health & Science University (US)
Corresponding author: Beer, Tomasz M.
ORCID: Fromme, Erik K.
Mori, Motomi
Beer, Tomasz M.
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2004-09-01
Volume: 22
Issue: 17
Pages: 3485-3490
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2004.03.025
OpenAlex: W2150906637
Cited by: 555
References: 32
Citations by year: 2026: 12 · 2025: 15 · 2024: 40 · 2023: 35 · 2022: 56 · 2021: 41 · 2020: 45 · 2019: 34 · 2018: 38 · 2017: 44 · 2016: 32 · 2015: 32 · 2014: 17 · 2013: 17 · 2012: 14
FWCI: 4.16
Type: journal article
Language: en
Open access: closed
Locations: Journal of Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P30 CA 69533, P30CA069533)
National Center for Research Resources (3 M01RR00334-33S2, M01RR000334)
Topics: Health Sciences › Medicine › Oncology › Cancer survivorship and care
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords: chemotherapy side effects, patient-reported symptoms, EORTC QLQ-C30, castration-resistant prostate cancer, metastatic prostate cancer, docetaxel, 1,25-dihydroxyvitamin D3, adverse event reporting, quality of life assessment
MeSH terms: Antineoplastic Combined Chemotherapy Protocols, Humans, Male, Physicians, Prostatic Neoplasms, Quality of Life, Surveys and Questionnaires, Sensitivity and Specificity, Adverse Drug Reaction Reporting Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks